EUVIMEDObjevte EUVIMED
Crossref

Vitiligo, morphea and Sjögren’s syndrome: a case study

Sema Yilmaz, Kadriye Akar Cimen

Rheumatology Reports · 2009

DOI: 10.4081/rr.2009.e7 ↗

At a glance

Journal article in Rheumatology Reports, 2009. Written by Sema Yilmaz and 1 co-authors.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

A 56-year-old woman was admitted to the rheumatology clinic with symptoms of burning and the feeling of grit or sand in her eyes. She also had dryness of the mouth, giving rise to difficulties with speech and swallowing food. The presence of anti-Ro/SSA and anti-La/SSB autoantibodies, and grade 4 chronic lymphocytic sialadenitis on biopsy of the salivary gland, together with the clinical findings revealed Sjögren’s syndrome. The patient was referred to the dermatology clinic because of widespread depigmentation in the middle of her back (Figure 1). Following the dermatological examination, the patient was considered to have vitiligo. With the help of Wood’s light examination, the diagnosis was confirmed. Another remarkable dermatological finding was violaceous-colored, slightly depressed and atrophic oval plaques of variable size (10x10 cm to 7x8 cm) on the abdominal and gluteal regions (Figure 2). Histopathological examination of these lesions demonstrated morphea. The patient was unaware of these dermatological conditions. In her past history, the patient had received radioactive iodine therapy for an adenoma of the thyroid gland eight years ago. In the family history, her daughter had been diagnosed with rheumatoid arthritis. Systemic examination of the patient was unremarkable. There was no systemic involvement associated with the morphea and Sjögren’s syndrome. Laboratory findings for a complete blood cell count, vitamin B12 levels, biochemical analysis, and urinalysis were normal. However, on admission abnormal laboratory findings included: erythrocyte sedimentation rate, 30 mm/hour (normal range, 0-20 mm/hr); C-reactive protein, 3 mg/L (0-5 mg/L); rheumatoid factor (RF), 604 IU/ml (0-15 IU/mL); and antinuclear antibody (ANA), 1/320 granular pattern. While anti-Ro/SSA and anti-La/SSB antibodies were positive, anti-double-stranded DNA (anti-dsDNA), and anti-centromere antibody were negative. A biopsy of the salivary gland revealed grade 4 chronic lymphocytic sialadenitis based on the Chilsom classification. Schirmer’s tear test was used for the evaluation of tear secretion by the lacrimal glands. There was wetting of less than 5 mm per 5 min. This demonstrated a strong indication of diminished secretion. Autoimmune etiology is thought to play a role in these diseases. Sjögren’s syndrome is an autoimmune disorder with a higher female incidence, distinctive human leukocyte antigen (HLA) associations, familial clustering with other autoimmune processes, and the presence of autoantibodies, such as antiRo/SSA and anti-La/SSB antibodies. The association of vitiligo with autoimmune diseases has suggested an immunological basis for vitiligo. Involvement of humoral immunity was first demonstrated by the finding of circulating antibodies directed to melanocytes. The vitiligo antibodies are attracted predominantly to various melanocyte antigens, including tyrosinase, tyrosinase-related protein 1, and tyrosinase-related protein 2. Recently, autoantibodies to a transcription factor called S0X10 have been found in vitiligo related to polyglandular dysfunction. Some studies have indicated an association of autoimmune diseases with morphea. In addition to positive titers of ANA, antidsDNA, and anti-scleroderma (-Scl) 70 antibodies, increased RF levels suggest that an immunological process occurring in morphea. Although Sjögren’s syndrome, vitiligo, and morphea are autoimmune diseases, they are seen together rarely. A few studies have reportCorrespondence: Sema Yilmaz, Vatan cad. Devrim sitesi B/Blok No: 25/4, 42040 Selcuklu, Konya, Turkey. E-mail: drsemayilmaz@hotmail.com/ drsemayilmaznew@gmail.com

Cite

APA

Yilmaz, S., & Cimen, K. A. (2009). Vitiligo, morphea and Sjögren’s syndrome: a case study. Rheumatology Reports. https://doi.org/10.4081/rr.2009.e7

Vancouver

Yilmaz S, Cimen KA. Vitiligo, morphea and Sjögren’s syndrome: a case study. Rheumatology Reports. 2009. doi:10.4081/rr.2009.e7

BibTeX
@article{Yilmaz2009,
  author = {Yilmaz, Sema and Cimen, Kadriye Akar},
  title = {Vitiligo, morphea and Sjögren’s syndrome: a case study},
  journal = {Rheumatology Reports},
  year = {2009},
  doi = {10.4081/rr.2009.e7}
}
Start for free →